An official website of the United States government
Here's how you know
Official websites use .mil
A
.mil
website belongs to an official U.S. Department of Defense organization in the United States.
Secure .mil websites use HTTPS
A
lock (
lock
)
or
https://
means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.
Skip to main content (Press Enter).
Toggle navigation
Walter Reed Army Institute of Research (WRAIR)
Walter Reed Army Institute of Research (WRAIR)
Search
Search Walter Reed Army Institute of Research:
Search
Search Walter Reed Army Institute of Research:
Search
Home
About Us
Leadership
Commander
Command Sergeant Major
History
Mission and Vision
Biomedical Research
Center for Infectious Disease Research
Bacterial Diseases
Multidrug-Resistant Organism Repository and Surveillance Network
Diagnostics and Countermeasures
Emerging Infectious Diseases
Entomology
Experimental Therapeutics
Military HIV Research Program
Biologics Research & Development
One Health
Viral Diseases
Center for Military Psychiatry and Neuroscience
CMPN Training Products
Deployment Cycle Resilience Training
Behavioral Biology
Blast Induced Neurotrauma
Brain Trauma Neuroprotection
Medical Readiness Systems Biology
Military Psychiatry
Research Transition Office
Global Research
Collaborate
Medical Standards Analytics and Research
Insectary
Library Archival Collection
Pilot Bioproduction Facility
Statistics and Epidemiology
Veterinary Services
Human Subjects Protection
Leishmania Diagnostics Laboratory
Join a Study
Sleep Research Center
Clinical Trials Center
Join Our Team
Army Civilian Positions at WRAIR
Community Engagement
Science Education and Fellowship Programs
News & Media
Investigators Dispatch & Fact Sheets
Press Releases
News/Features
Photos
Podcasts
Home
Biomedical Research
Center for Infectious Disease Research
Bacterial Diseases
Multidrug-Resistant Organism Repository and Surveillance Network
MRSN
The Multidrug-Resistant Organism Repository and Surveillance Network (MRSN), a department within WRAIR's
Bacterial Diseases Branch
, is a unique entity that serves as the primary surveillance organization for antibiotic-resistant bacteria across the Army, Navy and Air Force. The MRSN focuses on the so-called “ESKAPE-E” pathogens (
Enterococcus faecium
(vancomycin-resistant),
Staphylococcus aureus
(methicillin-resistant)
Klebsiella pneumoniae
,
Acinetobacter baumannii
,
Pseudomonas aeruginosa
,
Enterobacter
spp. and
Escherichia coli
), the most common bacteria in humans that are associated with antibiotic resistance.
The MRSN maintains these submissions in the DOD's only large-scale repository of multidrug-resistant (MDR) bacterial isolates, currently housing over 82,000 bacterial samples collected from patients treated across the Military Health System (MHS). The laboratory receives 800-1200 new samples every month from combat support hospitals across the world and routinely collaborates with other U.S. government agencies, allied partner nations and academic and civilian research institutions.
MRSN Directly Impacts DOD Readiness and Force Health Protection by:
Providing near real-time analysis for the geographic combatant commands of the prevalence and mobility of “superbugs” within their area of operation to better prepare medical personnel to treat war wound infections
Conducting retrospective and prospective analyses of antibiotic resistance trends and bacterial epidemiology across the entire MHS to improve performance and enhance infection control
Assisting military healthcare centers to detect and appropriately respond to potential outbreaks using the most advanced and accurate molecular methods available
Bacterial Diversity Panels:
The MRSN has developed bacterial diversity panels which include 100 genetically diverse strains of the same bacterial species. These diversity panels, available free of charge, are a valuable tool to researchers seeking to test novel, investigational antibiotics and other bacterial countermeasures. Currently a panel is available for
Pseudomonas aeruginosa
, with other diversity panels currently under development.
A Partnership with the MRSN will:
Improve patient outcomes by rapidly characterizing MDR infections to inform treatment decisions
Facilitate the sharing of epidemiologic information
Assist hospitals in meeting joint commission accreditation requirements for infection control and patient safety, as well as mandatory state reporting rules
Increase the likelihood of earlier detection of an outbreak or emerging pathogen
Provide cost savings to participating institutions
Contact Us
Enter Your Name
First
Last
*
Email
*
Phone
Send Us A Message
ReCaptcha V3 error.
Submit
MRDC FAMILY